Paradigm Biopharmaceuticals (PAR) | Bell Potter Healthcare Conference 2025LikeFollowSharePaul Rennie, Managing Director at Paradigm Biopharmaceuticals (PAR) presents at the Bell Potter Healthcare Conference 2025.Share your feedbackQuestions (0)Post questionYour question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.Start the conversationAsk Paradigm Biopharmaceuticals a question about this update.Discover
